TELA · TELA Bio, Inc.

NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD

TELA Bio Inc (TELA)

NASDAQ NMS - GLOBAL MARKET Health Care
Move probability → Options chain →
$1.11 +0.11 (+10.45%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE $1.11
$1.11 $1.11
52-WEEK RANGE $1.11
$0.50 $1.56

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$52.4M
P/E (TTM1)—
EPS2 (TTM)$-0.77
Div Yield—
Beta31.42
Volume1,646
Open1.11
Prev Close1.00
Bid / Ask0.90 / 1.29
Next Earnings 2026-11-11

Analyst Recommendations

Strong buy 3 Buy 7 Hold 2 Sell 0 Strong sell 0

Aggregate ratings for 2026-10-01 (12 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
TELA -7.63%
vs S&P 500 -20.40%
1-YEAR RETURN
TELA -26.35%
vs S&P 500 -40.91%
6-MONTH RETURN
TELA +48.74%
3-MONTH RETURN
TELA +51.30%

Valuation Measures & Ratios

Enterprise Value4$76.2M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)0.63
Price / Book78.32
EV4 / Revenue0.95
EV4 / EBITDA—
Profit Margin-51.53%
Operating Margin-43.67%
Return on Equity (ROE8)-441.55%
Return on Assets (ROA9)-60.42%
Avg Volume (3M)186,580
Quarterly history (5 periods)
Measure Jun '26Mar '26Sep '25Jun '25Mar '25
Market cap $42.2M $37.6M $67.0M $86.6M $54.7M
P/E -1.00 -0.89 -1.67 -1.96 -1.37
Price/Sales 0.53 0.48 0.86 1.17 0.78
Price/Book -2.66 -7.22 43.04 9.43 3.02
EV/Revenue 0.86 0.69 1.01 1.26 0.76
ROE 265.10% 808.75% -2579.45% -480.83% -220.15%
ROA -70.41% -60.18% -65.21% -65.38% -51.65%

Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).

Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short469,145
Change from Prior Settlement-14.83%
% of Float—
Days to Cover (Short Ratio)1.79

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

  • Latest SEC filing is Form 4, filed 2026-10-19; review it for current changes and risks. SEC EDGAR ↗

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Revenue $19.3M $19.1M $20.7M $20.2M $18.5M $19.0M $16.1M $16.6M
Gross profit $13.9M $12.5M $14.0M $14.1M $12.5M $12.9M $11.1M $11.3M
Operating income -$9.3M -$10.5M -$7.6M -$9.1M -$10.5M -$9.4M -$11.6M -$4.8M
Net income -$11.3M -$12.3M -$8.6M -$9.9M -$11.3M -$10.4M -$12.6M -$5.7M
EPS (diluted) $-0.20 $-0.21 $-0.19 $-0.22 $-0.25 $-0.42 $-0.51 $-0.23
EPS (basic) $-0.20 $-0.21 $-0.19 $-0.22 $-0.25 $-0.42 $-0.51 $-0.23

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $59.7M $69.9M $81.4M $61.6M $67.5M $77.3M $86.6M $53.0M
Total liabilities $75.6M $75.1M $75.1M $60.0M $58.4M $59.1M $58.1M $59.3M
Stockholders' equity -$15.9M -$5.2M $6.3M $1.6M $9.2M $18.1M $28.5M -$6.3M
Total current assets $54.5M $64.3M $75.6M $56.0M $60.7M $69.7M $78.1M $44.1M
Total current liabilities $18.2M $17.8M $18.0M $17.0M $19.1M $16.5M $15.6M $16.9M
Cash & equivalents $30.4M $39.5M $50.8M $29.7M $35.0M $42.8M $52.7M $17.3M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$9.4M -$11.2M -$4.9M -$5.7M -$7.9M -$9.7M -$7.5M -$9.0M
Investing cash flow $239.0K $190.0K $192.0K $312.0K $204.0K $138.0K -$190.0K -$122.0K
Financing cash flow -$15.0K -$298.0K $25.8M $24.0K -$3.0K -$116.0K $42.9M $98.0K
Free cash flow -$9.4M -$11.3M -$5.0M -$5.9M -$8.0M -$9.8M -$7.8M -$9.1M
Capital expenditures $59.0K $119.0K $91.0K $211.0K $114.0K $32.0K $264.0K $122.0K
Share-based compensation $613.0K $816.0K $812.0K $955.0K $985.0K $1.0M $1.1M $1.1M

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding TELA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-08-03 to 2026-10-15

Recent transactions

  • Insiders have net bought 177,500 shares over the last 182 days, across 6 purchases and 0 sales.
  • Most recent: Capper Joseph H (Reporting person) — Grant / award of 19,801 shares on 2026-10-15.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)177,500 sh(6 txns)
Sales (open market)0 sh(0 txns)
Net Shares+177,500

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Capper Joseph HReporting personGrant / award2026-10-1519,801
Plovanic William J.Reporting personGrant / award2026-10-1516,089
Getz Heather CChief Executive OfficerOpen market purchase2026-08-1712,500
Rocchio Betty JoReporting personGrant / award2026-06-0911,675
NEELS GUIDO JReporting personGrant / award2026-06-0911,925
THOMAS PAULReporting personGrant / award2026-06-0911,925
NOHRA GUY PReporting personGrant / award2026-06-0911,925
KOBLISH ANTONYChief Executive OfficerTax withholding2026-02-243,900
Firestone Gregory A.Chief Business OfficerTax withholding2026-02-231,352
Talmo PaulChief Technology OfficerTax withholding2026-02-234,061
Cuca RobertoCOO and CFOTax withholding2026-02-235,234
Smeykal MeganChief Accounting OfficerTax withholding2026-02-23423
Blizard JeffreyPresidentGrant / award2026-02-2086,000
EW HEALTHCARE PARTNERS FUND 2, L.P.Reporting personOpen market purchase2025-11-173,604,000

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-10-15Capper Joseph HReporting personGrant / award 19,801$1.01
2026-10-15Plovanic William J.Reporting personGrant / award 16,089$1.01
2026-09-17Capper Joseph HReporting personOpen market purchase 25,000$1.22
2026-09-16Capper Joseph HReporting personOpen market purchase 50,000$1.17
2026-09-15Capper Joseph HReporting personOpen market purchase 50,000$1.06
2026-09-14Capper Joseph HReporting personOpen market purchase 25,000$1.02
2026-08-17Getz Heather CChief Executive OfficerOpen market purchase 12,500$0.66
2026-08-14Getz Heather CChief Executive OfficerOpen market purchase 15,000$0.70
2026-08-03Getz Heather CChief Executive OfficerGrant / award 500,000$0.00
2026-07-15Plovanic William J.Reporting personGrant / award 20,930$0.79
2026-07-15Capper Joseph HReporting personGrant / award 6,227$0.79
2026-06-09Rocchio Betty JoReporting personGrant / award 11,675$0.00
2026-06-09Capper Joseph HReporting personGrant / award 11,925$0.00
2026-06-09Capper Joseph HReporting personGrant / award 11,675$0.00
2026-06-09Plovanic William J.Reporting personGrant / award 11,675$0.00
2026-06-09NEELS GUIDO JReporting personGrant / award 11,925$0.00
2026-06-09NEELS GUIDO JReporting personGrant / award 11,675$0.00
2026-06-09THOMAS PAULReporting personGrant / award 11,925$0.00
2026-06-09THOMAS PAULReporting personGrant / award 11,675$0.00
2026-06-09NOHRA GUY PReporting personGrant / award 11,925$0.00
2026-06-09NOHRA GUY PReporting personGrant / award 11,675$0.00
2026-02-24KOBLISH ANTONYChief Executive OfficerTax withholding 3,900$0.79
2026-02-23KOBLISH ANTONYChief Executive OfficerTax withholding 11,631$0.77
2026-02-23Firestone Gregory A.Chief Business OfficerTax withholding 1,352$0.77
2026-02-23Talmo PaulChief Technology OfficerTax withholding 4,061$0.77
2026-02-23Cuca RobertoCOO and CFOTax withholding 5,234$0.77
2026-02-23Smeykal MeganChief Accounting OfficerTax withholding 423$0.77
2026-02-21KOBLISH ANTONYChief Executive OfficerTax withholding 12,494$0.72
2026-02-21Firestone Gregory A.Chief Business OfficerTax withholding 4,189$0.72
2026-02-21Talmo PaulChief Technology OfficerTax withholding 3,385$0.72
2026-02-21Cuca RobertoCOO and CFOTax withholding 4,780$0.72
2026-02-21Smeykal MeganChief Accounting OfficerTax withholding 1,590$0.72
2026-02-20KOBLISH ANTONYChief Executive OfficerGrant / award 176,000$0.00
2026-02-20Firestone Gregory A.Chief Business OfficerGrant / award 37,000$0.00
2026-02-20Talmo PaulChief Technology OfficerGrant / award 57,000$0.00
2026-02-20Cuca RobertoCOO and CFOGrant / award 57,000$0.00
2026-02-20Blizard JeffreyPresidentGrant / award 86,000$0.00
2026-02-19Smeykal MeganChief Accounting OfficerTax withholding 795$0.80
2026-02-18Smeykal MeganChief Accounting OfficerGrant / award 32,850$0.00
2025-11-17EW HEALTHCARE PARTNERS FUND 2, L.P.Reporting personOpen market purchase 3,604,000$1.11
2025-10-31Plovanic William J.Reporting personGrant / award 11,925$0.00
2025-10-09Rocchio Betty JoReporting personGrant / award 11,925$0.00
2025-08-03Firestone Gregory A.Chief Commercial OfficerTax withholding 1,093$1.86

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-22 07:51 UTC

FiledFormReport periodOfficial filing
2026-10-1942026-10-15 View on SEC.gov →
2026-10-1942026-10-15 View on SEC.gov →
2026-10-088-K2026-10-08 View on SEC.gov →
2026-10-068-K2026-10-05 View on SEC.gov →
2026-10-058-K2026-10-05 View on SEC.gov →
2026-09-298-K2026-09-28 View on SEC.gov →
2026-09-1842026-09-16 View on SEC.gov →
2026-09-188-K2026-09-15 View on SEC.gov →
2026-09-1642026-09-14 View on SEC.gov →
2026-08-318-K2026-08-28 View on SEC.gov →
2026-08-1942026-08-17 View on SEC.gov →
2026-08-1742026-08-14 View on SEC.gov →

Headlines about TELA (TELA Bio, Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist